Cardiovascular risk in women with polycystic ovary syndrome.

Minerva endocrinologica

Volumn 32, Issue 4, 2007, Pages 263-273

  Cho, L W ^a   Atkin, S L ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; BIOLOGICAL MARKER; METFORMIN; PIOGLITAZONE; ROSIGLITAZONE; VASODILATOR AGENT;

ATHEROSCLEROSIS; BLOOD; BODY WEIGHT; CARDIOVASCULAR DISEASE; EXERCISE; FEMALE; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; OVARY POLYCYSTIC DISEASE; REVIEW; RISK FACTOR; RISK REDUCTION; WEIGHT REDUCTION;

ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BODY WEIGHT; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; EXERCISE; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; METFORMIN; POLYCYSTIC OVARY SYNDROME; RISK FACTORS; RISK REDUCTION BEHAVIOR; THIAZOLIDINEDIONES; VASODILATOR AGENTS; WEIGHT LOSS;

EID: 39749096632     PISSN: 03911977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (148)